Article
A gene signature predicting prognosis of patients with low- grade gliomas receiving temozolomide therapy
2023-04-19
Abstract excerpt
Temozolomide (TMZ) has been used as a first-line therapy against low-grade gliomas (LGGs) combined with other chemotherapy drugs. However, there has been no reliable index predicting TMZ response of patients with LGGs. In this study, we aim to investigate the relationship between gene expressions and the prognosis of TMZ therapy in LGGs. We integrated transcriptome and clinical data of 171 LGGs from the Chinese Gl...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 309c35bf-0db4-56ba-bf4e-2a12ba27b3d7
- DOI
- 10.21203/rs.3.rs-2822634/v1
